Results 231 to 240 of about 255,046 (288)

A preterm neonate with infantile liver failure syndrome 1 due to leucyl‐tRNA synthetase 1 gene (LARS1) mutations with a histopathologic phenotype of neonatal hemochromatosis

open access: yesJPGN Reports, EarlyView.
Abstract We report a case of a premature, growth‐restricted female infant with feeding intolerance and coagulopathy, treated initially for sepsis, who progressed to neonatal acute liver failure and end‐stage hepatic encephalopathy after a prolonged hospitalization with extensive diagnostic evaluation, and was found by autopsy to have histopathologic ...
Adrienne Bruder   +3 more
wiley   +1 more source

Effects of post‐hepatic portoenterostomy adjuvant therapy on liver transplantation in children with biliary atresia: A systematic review

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Biliary atresia (BA) is a cholangiopathy characterized by obstruction of the intrahepatic and extrahepatic bile ducts. Hepatic portoenterostomy (HPE) is the primary palliative treatment and there is still an urgent need to improve post‐HPE management.
Bianca Ferraz de Almeida Silva   +7 more
wiley   +1 more source

[Intravenous immunoglobulins: this is it!].

open access: yesAnales de medicina interna (Madrid, Spain : 1984), 1993
openaire   +1 more source

Use of Intravenous Immunoglobulins in Sepsis Therapy—A Clinical View

open access: yesInternational Journal of Molecular Sciences, 2020
Sepsis is a life-threatening organ dysfunction, defined by a dysregulated host immune response to infection. During sepsis, the finely tuned system of immunity, inflammation and anti-inflammation is disturbed in a variety of ways.
Axel Nierhaus   +2 more
exaly   +2 more sources

Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature

open access: yesAutoimmunity Reviews, 2015
Granulomatosis with polyangiitis, formerly known as Wegener's granulomatosis or disease, is a systemic, necrotizing small-vessel vasculitis, belonging to the group of anti-neutrophil cytoplasm antibody vasculitis.
Sara Tenti   +2 more
exaly   +2 more sources

Safety of Intravenous Immunoglobulin

Archives of Neurology, 1993
The current position of intravenous immunoglobulin (IVIG) in neurology is similar to that of plasmapheresis 10 years ago. Therapeutic claims have been made for an increasing number of neurologic disorders, based on small, uncontrolled studies. With the recent publication of a controlled trial of IVIG treatment in Guillain-Barre syndrome, 1 and trials ...
C A, Thornton, M, Ballow
openaire   +2 more sources

Intravenous Immunoglobulin and Fibrosis

Clinical Reviews in Allergy & Immunology, 2005
Fibrosis is a pathological process that includes scar formation and overproduction of extracellular matrix by the connective tissue as a response to tissue damage. Pathologies include pathological scarring as colloid and hypertrophic scars in the skin, cirrhosis of liver and gallbladder, pulmonary and bone-marrow fibrosis, and scleroderma.
Vered, Molina   +2 more
openaire   +2 more sources

Intravenous Immunoglobulin and Atherosclerosis

Clinical Reviews in Allergy & Immunology, 2005
Several inflammatory and immunological factors have been established as important contributors to atherogenesis. Among these, oxidized low-density lipoprotein (oxLDL) play a central role in the initiation and progression of atherosclerotic lesions. In atherosclerotic lesions, oxLDL was also found to co-localize with beta2-glycoprotein I (beta2-GPI ...
Eiji, Matsuura   +3 more
openaire   +2 more sources

Therapeutic intravenous immunoglobulins

Molecular Immunology, 2005
Intravenous immunoglobulins (IVIg) are concentrated formulations of human IgG prepared by industrial fractionation of large pools of individual plasma donations. IVIg were developed 20 years ago for the prophylaxis support of immunodeficient patients.
Réal, Lemieux   +2 more
openaire   +2 more sources

Immunomodulation by Intravenous Immunoglobulin

Journal of Pediatric Hematology/Oncology, 1990
In 1980, it was observed in a child with idiopathic thrombocytopenic purpura (ITP) that intravenous administration of pooled human immunoglobulin-G (IVIG) was followed by a rapid increase of the platelet count. Prompted by this finding, a pilot study and two prospective multicenter studies on children with ITP were organized.
P, Imbach   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy